Par Drugs and Chemicals (NSE:PAR) ROCE % : 3.14% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Par Drugs and Chemicals's annualized ROCE % for the quarter that ended in Dec. 2024 was 3.14%.

Par Drugs and Chemicals ROCE % Historical Data

The historical data trend for Par Drugs and Chemicals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals ROCE % Chart

Par Drugs and Chemicals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

15.32

27.95

21.06

21.75

23.79

Par Drugs and Chemicals Quarterly Data
	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															22.31	22.64	15.27	45.93	3.14

Par Drugs and Chemicals ROCE % Calculation

Par Drugs and Chemicals's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	195.166	/	( ( (888.679 - 139.894)	+	(1016.111 - 124.391) )	/ 2 )
	=	195.166	/	( (748.785	+	891.72)	/ 2 )
	=	195.166	/	820.2525
	=	23.79 %

Par Drugs and Chemicals's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	31.46	/	( ( (1156.549 - 153.54)	+	(0 - 0) )	/ 1 )
	=	31.46	/	( ( 1003.009	+	0 )	/ 1 )
	=	31.46	/	1003.009
	=	3.14 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Par Drugs and Chemicals (NSE:PAR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Par Drugs and Chemicals ROCE % Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Par Drugs and Chemicals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007

Website

https://www.pardrugs.com

Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage. The company is dealing in only one segment i.e. manufacturing industry, API.